These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18654864)

  • 41. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
    Basarkar A; Devineni D; Palaniappan R; Singh J
    Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers.
    Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD
    Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs.
    Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK
    Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo investigation of drug-eluting implants for the treatment of periodontal disease.
    Lee FY; Chen DW; Hu CC; Hsieh YT; Liu SJ; Chan EC
    AAPS PharmSciTech; 2011 Dec; 12(4):1110-5. PubMed ID: 21879391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation.
    Gad HA; Kamel AO; Ezzat OM; El Dessouky HF; Sammour OA
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1241-1251. PubMed ID: 28485988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multifunctional poly(β-amino ester) hydrogel microparticles in periodontal in situ forming drug delivery systems.
    Fisher PD; Clemens J; Zach Hilt J; Puleo DA
    Biomed Mater; 2016 Mar; 11(2):025002. PubMed ID: 26947556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
    Jain RA
    Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery.
    Rauta PR; Das NM; Nayak D; Ashe S; Nayak B
    IET Nanobiotechnol; 2016 Aug; 10(4):254-61. PubMed ID: 27463797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
    J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
    Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
    Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation.
    Ahuja A; Ali J; Rahman S
    Pharmazie; 2006 Jan; 61(1):25-9. PubMed ID: 16454202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interdependency of protein-release completeness and polymer degradation in PLGA-based implants.
    Ghalanbor Z; Körber M; Bodmeier R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):624-30. PubMed ID: 23583495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation.
    Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD
    J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
    Prior S; Gander B; Blarer N; Merkle HP; Subirá ML; Irache JM; Gamazo C
    Eur J Pharm Sci; 2002 Mar; 15(2):197-207. PubMed ID: 11849917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards developing surface eroding poly(alpha-hydroxy acids).
    Xu XJ; Sy JC; Prasad Shastri V
    Biomaterials; 2006 May; 27(15):3021-30. PubMed ID: 16455136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables.
    Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH
    Eur J Pharm Biopharm; 2000 Sep; 50(2):257-62. PubMed ID: 10962236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.